aluates Reports

$ 0.0

Automative

Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-32W13631

Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Research Report 2023

BUY CHAPTERS

Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Research Report 2025

Code: QYRE-Auto-32W13631

Report

May 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Seattle Genetics Inc

ImmunoGen Inc

Ambrx Inc

Catalent Biologics

Immunomedics

Mersana Therapeutics

Sutro Biopharma

LegoChem Biosciences

Linxis

ADC Therapeutics

Iksuda Therapeutics

Antibody Drug Conjugate Linker And Conjugation Technologies Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Antibody Drug Conjugate Linker And Conjugation Technologies Market

The global market for Antibody Drug Conjugate Linker And Conjugation Technologies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Antibody Drug Conjugate Linker And Conjugation Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Drug Conjugate Linker And Conjugation Technologies.

The Antibody Drug Conjugate Linker And Conjugation Technologies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody Drug Conjugate Linker And Conjugation Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antibody Drug Conjugate Linker And Conjugation Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antibody Drug Conjugate Linker And Conjugation Technologies Market Report

Report Metric	Details
Report Name	Antibody Drug Conjugate Linker And Conjugation Technologies Market
CAGR	5%
Segment by Type	Chemical Conjugation Enzymatic Conjugation
Segment by Application	Leukemia Lymphoma Breast Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Seattle Genetics Inc, Immunogen, Ambrx, Catalent Biologics, Immunomedics, Mersana Therapeutics, Sutro Biopharma, Iksuda Therapeutics, Legochem Biosciences, Linxis, Adc Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Drug Conjugate Linker And Conjugation Technologies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antibody Drug Conjugate Linker And Conjugation Technologies Market report?

Ans: The main players in the Antibody Drug Conjugate Linker And Conjugation Technologies Market are Seattle Genetics Inc, Immunogen, Ambrx, Catalent Biologics, Immunomedics, Mersana Therapeutics, Sutro Biopharma, Iksuda Therapeutics, Legochem Biosciences, Linxis, Adc Therapeutics

What are the Application segmentation covered in the Antibody Drug Conjugate Linker And Conjugation Technologies Market report?

Ans: The Applications covered in the Antibody Drug Conjugate Linker And Conjugation Technologies Market report are Leukemia, Lymphoma, Breast Cancer, Others

What are the Type segmentation covered in the Antibody Drug Conjugate Linker And Conjugation Technologies Market report?

Ans: The Types covered in the Antibody Drug Conjugate Linker And Conjugation Technologies Market report are Chemical Conjugation, Enzymatic Conjugation

Recommended Reports

Antibody and Drug Conjugates

Pharmaceutical Supply Chain

Drug Delivery Devices

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Chemical Conjugation

1.2.3 Enzymatic Conjugation

1.3 Market by Application

1.3.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Leukemia

1.3.3 Lymphoma

1.3.4 Breast Cancer

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Perspective (2020-2031)

2.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Growth Trends by Region

2.2.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Antibody Drug Conjugate Linker And Conjugation Technologies Historic Market Size by Region (2020-2025)

2.2.3 Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Region (2026-2031)

2.3 Antibody Drug Conjugate Linker And Conjugation Technologies Market Dynamics

2.3.1 Antibody Drug Conjugate Linker And Conjugation Technologies Industry Trends

2.3.2 Antibody Drug Conjugate Linker And Conjugation Technologies Market Drivers

2.3.3 Antibody Drug Conjugate Linker And Conjugation Technologies Market Challenges

2.3.4 Antibody Drug Conjugate Linker And Conjugation Technologies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Revenue

3.1.1 Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Revenue (2020-2025)

3.1.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Players (2020-2025)

3.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue

3.4 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Concentration Ratio

3.4.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue in 2024

3.5 Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies Head office and Area Served

3.6 Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies, Product and Application

3.7 Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Antibody Drug Conjugate Linker And Conjugation Technologies Breakdown Data by Type

4.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Historic Market Size by Type (2020-2025)

4.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Type (2026-2031)

5 Antibody Drug Conjugate Linker And Conjugation Technologies Breakdown Data by Application

5.1 Global Antibody Drug Conjugate Linker And Conjugation Technologies Historic Market Size by Application (2020-2025)

5.2 Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2020-2031)

6.2 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025)

6.4 North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2020-2031)

7.2 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025)

7.4 Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2020-2031)

8.2 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2020-2025)

8.4 Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2020-2031)

9.2 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025)

9.4 Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (2020-2031)

10.2 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025)

10.4 Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Seattle Genetics Inc

11.1.1 Seattle Genetics Inc Company Details

11.1.2 Seattle Genetics Inc Business Overview

11.1.3 Seattle Genetics Inc Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.1.4 Seattle Genetics Inc Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

11.1.5 Seattle Genetics Inc Recent Development

11.2 Immunogen

11.2.1 Immunogen Company Details

11.2.2 Immunogen Business Overview

11.2.3 Immunogen Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.2.4 Immunogen Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

11.2.5 Immunogen Recent Development

11.3 Ambrx

11.3.1 Ambrx Company Details

11.3.2 Ambrx Business Overview

11.3.3 Ambrx Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.3.4 Ambrx Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

11.3.5 Ambrx Recent Development

11.4 Catalent Biologics

11.4.1 Catalent Biologics Company Details

11.4.2 Catalent Biologics Business Overview

11.4.3 Catalent Biologics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.4.4 Catalent Biologics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

11.4.5 Catalent Biologics Recent Development

11.5 Immunomedics

11.5.1 Immunomedics Company Details

11.5.2 Immunomedics Business Overview

11.5.3 Immunomedics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.5.4 Immunomedics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

11.5.5 Immunomedics Recent Development

11.6 Mersana Therapeutics

11.6.1 Mersana Therapeutics Company Details

11.6.2 Mersana Therapeutics Business Overview

11.6.3 Mersana Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.6.4 Mersana Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

11.6.5 Mersana Therapeutics Recent Development

11.7 Sutro Biopharma

11.7.1 Sutro Biopharma Company Details

11.7.2 Sutro Biopharma Business Overview

11.7.3 Sutro Biopharma Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.7.4 Sutro Biopharma Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

11.7.5 Sutro Biopharma Recent Development

11.8 Iksuda Therapeutics

11.8.1 Iksuda Therapeutics Company Details

11.8.2 Iksuda Therapeutics Business Overview

11.8.3 Iksuda Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.8.4 Iksuda Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

11.8.5 Iksuda Therapeutics Recent Development

11.9 Legochem Biosciences

11.9.1 Legochem Biosciences Company Details

11.9.2 Legochem Biosciences Business Overview

11.9.3 Legochem Biosciences Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.9.4 Legochem Biosciences Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

11.9.5 Legochem Biosciences Recent Development

11.10 Linxis

11.10.1 Linxis Company Details

11.10.2 Linxis Business Overview

11.10.3 Linxis Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.10.4 Linxis Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

11.10.5 Linxis Recent Development

11.11 Adc Therapeutics

11.11.1 Adc Therapeutics Company Details

11.11.2 Adc Therapeutics Business Overview

11.11.3 Adc Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Introduction

11.11.4 Adc Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

11.11.5 Adc Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Seattle Genetics Inc

ImmunoGen Inc

Ambrx Inc

Catalent Biologics

Immunomedics

Mersana Therapeutics

Sutro Biopharma

LegoChem Biosciences

Linxis

ADC Therapeutics

Iksuda Therapeutics

List of Tables

Table 1. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Chemical Conjugation

Table 3. Key Players of Enzymatic Conjugation

Table 4. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region (2020-2025)

Table 8. Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region (2026-2031)

Table 10. Antibody Drug Conjugate Linker And Conjugation Technologies Market Trends

Table 11. Antibody Drug Conjugate Linker And Conjugation Technologies Market Drivers

Table 12. Antibody Drug Conjugate Linker And Conjugation Technologies Market Challenges

Table 13. Antibody Drug Conjugate Linker And Conjugation Technologies Market Restraints

Table 14. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Players (2020-2025)

Table 16. Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies as of 2024)

Table 17. Ranking of Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies, Headquarters and Area Served

Table 20. Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies, Product and Application

Table 21. Global Key Players of Antibody Drug Conjugate Linker And Conjugation Technologies, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Type (2020-2025)

Table 25. Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Type (2026-2031)

Table 27. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Application (2020-2025)

Table 29. Global Antibody Drug Conjugate Linker And Conjugation Technologies Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Antibody Drug Conjugate Linker And Conjugation Technologies Revenue Market Share by Application (2026-2031)

Table 31. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Country (2026-2031) & (US$ Million)

Table 46. Seattle Genetics Inc Company Details

Table 47. Seattle Genetics Inc Business Overview

Table 48. Seattle Genetics Inc Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 49. Seattle Genetics Inc Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)

Table 50. Seattle Genetics Inc Recent Development

Table 51. Immunogen Company Details

Table 52. Immunogen Business Overview

Table 53. Immunogen Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 54. Immunogen Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)

Table 55. Immunogen Recent Development

Table 56. Ambrx Company Details

Table 57. Ambrx Business Overview

Table 58. Ambrx Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 59. Ambrx Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)

Table 60. Ambrx Recent Development

Table 61. Catalent Biologics Company Details

Table 62. Catalent Biologics Business Overview

Table 63. Catalent Biologics Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 64. Catalent Biologics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)

Table 65. Catalent Biologics Recent Development

Table 66. Immunomedics Company Details

Table 67. Immunomedics Business Overview

Table 68. Immunomedics Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 69. Immunomedics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)

Table 70. Immunomedics Recent Development

Table 71. Mersana Therapeutics Company Details

Table 72. Mersana Therapeutics Business Overview

Table 73. Mersana Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 74. Mersana Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)

Table 75. Mersana Therapeutics Recent Development

Table 76. Sutro Biopharma Company Details

Table 77. Sutro Biopharma Business Overview

Table 78. Sutro Biopharma Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 79. Sutro Biopharma Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)

Table 80. Sutro Biopharma Recent Development

Table 81. Iksuda Therapeutics Company Details

Table 82. Iksuda Therapeutics Business Overview

Table 83. Iksuda Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 84. Iksuda Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)

Table 85. Iksuda Therapeutics Recent Development

Table 86. Legochem Biosciences Company Details

Table 87. Legochem Biosciences Business Overview

Table 88. Legochem Biosciences Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 89. Legochem Biosciences Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)

Table 90. Legochem Biosciences Recent Development

Table 91. Linxis Company Details

Table 92. Linxis Business Overview

Table 93. Linxis Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 94. Linxis Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)

Table 95. Linxis Recent Development

Table 96. Adc Therapeutics Company Details

Table 97. Adc Therapeutics Business Overview

Table 98. Adc Therapeutics Antibody Drug Conjugate Linker And Conjugation Technologies Product

Table 99. Adc Therapeutics Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025) & (US$ Million)

Table 100. Adc Therapeutics Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Antibody Drug Conjugate Linker And Conjugation Technologies Picture

Figure 2. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Type: 2024 VS 2031

Figure 4. Chemical Conjugation Features

Figure 5. Enzymatic Conjugation Features

Figure 6. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Application: 2024 VS 2031

Figure 8. Leukemia Case Studies

Figure 9. Lymphoma Case Studies

Figure 10. Breast Cancer Case Studies

Figure 11. Others Case Studies

Figure 12. Antibody Drug Conjugate Linker And Conjugation Technologies Report Years Considered

Figure 13. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region: 2024 VS 2031

Figure 16. Global Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Players in 2024

Figure 17. Global Top Antibody Drug Conjugate Linker And Conjugation Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugate Linker And Conjugation Technologies as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Antibody Drug Conjugate Linker And Conjugation Technologies Revenue in 2024

Figure 19. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2020-2031)

Figure 21. United States Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2020-2031)

Figure 25. Germany Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Region (2020-2031)

Figure 33. China Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2020-2031)

Figure 41. Mexico Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Antibody Drug Conjugate Linker And Conjugation Technologies Market Share by Country (2020-2031)

Figure 45. Turkey Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Antibody Drug Conjugate Linker And Conjugation Technologies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Seattle Genetics Inc Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

Figure 49. Immunogen Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

Figure 50. Ambrx Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

Figure 51. Catalent Biologics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

Figure 52. Immunomedics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

Figure 53. Mersana Therapeutics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

Figure 54. Sutro Biopharma Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

Figure 55. Iksuda Therapeutics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

Figure 56. Legochem Biosciences Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

Figure 57. Linxis Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

Figure 58. Adc Therapeutics Revenue Growth Rate in Antibody Drug Conjugate Linker And Conjugation Technologies Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Antibody Drug Conjugation Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Peptide Drug Conjugates Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibody Drug Conjugate ADC Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Monoclonal Antibody Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Next Generation Antibody Drug Market Research Report 2024

Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Next Generation Immunology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immune Drugs Market Insights Forecast to 2030

Bispecific Antibody Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Clinical Grade Antibody Portfolio Market Research Report 2025

Viral Conjunctivitis Pipeline Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical Retail Chain Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Image Guided Therapy Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nanotechnology Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Injectable Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Counters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions